Long-Term Sulfonylurea Use and Impaired Awareness of Hypoglycemia Among Patients With Type 2 Diabetes in Taiwan

被引:0
|
作者
Cheng, Hsiang-Ju [1 ]
Weng, Siou-Huei [2 ,3 ]
Wu, Jia-Ling [2 ]
Yeh, Shu-Tin [4 ]
Chen, Hua-Fen [4 ,5 ,6 ]
Novida, Hermina [7 ]
Ou, Huang-Tz [8 ,9 ,10 ]
Li, Chung-Yi [2 ,11 ,12 ]
机构
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Family Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, 1 Univ Rd, Tainan 701, Taiwan
[3] Tainan City Govt, Publ Hlth Bur, Dis Control Sect Div, Tainan, Taiwan
[4] Far Eastern Mem Hosp, Dept Endocrinol, New Taipei City, Taiwan
[5] Fu Jen Catholic Univ, Coll Med, Dept Med, New Taipei City, Taiwan
[6] Fu Jen Catholic Univ, Coll Med, Dept Publ Hlth, New Taipei City, Taiwan
[7] Univ Airlangga, Fac Med, Dept Internal Med, Div Endocrine Metab & Diabet, Surabaya, Indonesia
[8] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[9] Natl Cheng Kung Univ, Coll Med, Dept Pharm, Tainan, Taiwan
[10] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan, Taiwan
[11] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
[12] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan
关键词
hypoglycemia; type; 2; diabetes; sulfonylurea; insulin; hypoglycemic agents; glycemic control; risk factors; diabetes complications; primary care; MECHANISMS; FREQUENCY;
D O I
10.1370/afm.3129
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE We undertook a study to investigate the relationship between duration of medication use and prevalence of impaired awareness of hypoglycemia (IAH) among patients with insulin-treated or sulfonylurea-treated type 2 diabetes in Taiwan. METHODS A total of 898 patients (41.0% insulin users, 65.1% sulfonylurea users; mean [SD] age = 59.9 [12.3] years, 50.7% female) were enrolled in pharmacies, clinics, and health bureaus of Tainan City, Taiwan. Presence of IAH was determined with Chinese versions of the Gold questionnaire (Gold-TW) and Clarke questionnaire (Clarke-TW). Sociodemographics, disease and treatment histories, diabetes-related medical care, and health status were collected. We used multiple logistic regression models to assess the relationship between duration of medication use and IAH. RESULTS Overall IAH prevalence was 41.0% (Gold-TW) and 28.2% (Clarke-TW) among insulin users, and 65.3% (Gold-TW) and 51.3% (Clarke-TW) among sulfonylurea users. Prevalence increased with the duration of sulfonylurea use, whereas it decreased with the duration of insulin use. After controlling for potential confounders, 5 or more years of sulfonylurea use was significantly associated with 3.50-fold (95% CI, 2.39-5.13) and 3.06-fold (95% CI, 2.114.44) increases in the odds of IAH based on the Gold-TW and Clarke-TW criteria, respectively. On the other hand, regular blood glucose testing and retinal examinations were associated with reduced odds in both insulin users and sulfonylurea users. CONCLUSIONS The prevalence of IAH was high among patients using sulfonylureas long term, but the odds of this complication were attenuated for those who received regular diabetes-related medical care. Our study suggests that long-term sulfonylurea use and irregular follow-up increase risk for IAH. Further prospective studies are needed to confirm the observed associations. Ann Fam Med 2024;22:309-316. https://doi.org/10.1370/afm.3129 Annals Early Access article
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [21] Cerebral blood flow response to hypoglycemia is altered in patients with type 1 diabetes and impaired awareness of hypoglycemia
    Wiegers, Evita C.
    Becker, Kirsten M.
    Rooijackers, Hanne M.
    von Samson-Himmelstjerna, Federico C.
    Tack, Cees J.
    Heerschap, Arend
    de Galan, Bastiaan E.
    van der Graaf, Marinette
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 (06): : 1994 - 2001
  • [22] Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes
    Xu, Yang
    Yang, Zhirong
    Lin, Hongbo
    Shen, Peng
    Wang, Haining
    Zhan, Siyan
    MEDICAL SCIENCE MONITOR, 2018, 24 : 8707 - 8715
  • [23] Impaired Awareness and Symptomatology of Hypoglycemia in Adults With Type 1 Diabetes Using Continuous Glucose Monitoring
    Lin, Yu Kuei
    Ye, Wen
    Hepworth, Emily
    Rickels, Michael R.
    Amiel, Stephanie A.
    Speight, Jane
    Shaw, James A. M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [24] Prevalence of impaired awareness of hypoglycemia and identification of predictive symptoms in children and adolescents with type 1 diabetes
    Graveling, Alex J.
    Noyes, Kathryn J.
    Allerhand, Michael H.
    Wright, Rohana J.
    Bath, Louise E.
    Deary, Ian J.
    Frier, Brian M.
    PEDIATRIC DIABETES, 2014, 15 (03) : 206 - 213
  • [25] Type 1 Diabetes and Impaired Awareness of Hypoglycemia Are Associated with Reduced Brain Gray Matter Volumes
    Bednarik, Petr
    Moheet, Amir A.
    Grohn, Heidi
    Kumar, Anjali F.
    Eberly, Lynn E.
    Seaquist, Elizabeth R.
    Mangia, Silvia
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [26] Healthcare resource use and associated costs of hypoglycemia in patients with type 2 diabetes prescribed sulfonylureas
    Alemayehu, Berhanu
    Liu, Jinan
    Rajpathak, Swapnil
    Engel, Samuel S.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (11) : 1620 - 1623
  • [27] Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
    Soliman, Amin
    El Kordy, Noran Atef
    Faris, Farouk Mostafa
    Ahmed, Rabab Mahmoud
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01):
  • [28] Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
    Heaton, Pamela C.
    Desai, Vibha C. A.
    Kelton, Christina M. L.
    Rajpathak, Swapnil N.
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [29] Long-Term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom
    Pradhan, Richeek
    Yu, Oriana
    Platt, Robert W.
    Azoulay, Laurent
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 185
  • [30] Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
    Shi, Qian
    Lin, Yilu
    Fonseca, Vivian A.
    Shi, Lizheng
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)